Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Object. The aim of this study was to evaluate the long-term safety and efficacy of bilateral contemporaneous deep brain stimulation (DBS) in patients who have levodopa-responsive parkinsonism with untreatable motor fluctuations. Bilateral pallidotomy carries a high risk of corticobulbar and cognitive dysfunction. Deep brain stimulation offers new alternatives with major advantages such as reversibility of effects, minimal permanent lesions, and adaptability to individual needs, changes in medication, side effects, and evolution of the disease. Methods. Patients in whom levodopa-responsive parkinsonism with untreatable severe motor fluctuations has been clinically diagnosed underwent bilateral pallidal magnetic resonance image—guided electrode implantation while receiving a local anesthetic. Pre- and postoperative evaluations at 3-month intervals included Unified Parkinson's Disease Rating Scale (UPDRS) scoring, Hoehn and Yahr staging, 24-hour self-assessments, and neuropsychological examinations. Six patients with a mean age of 55 years (mean 42–67 years), a mean duration of disease of 15.5 years (range 12–21 years), a mean “on/off” Hoehn and Yahr stage score of 3/4.2 (range 3–5), and a mean “off” time of 40% (range 20–50%) underwent bilateral contemporaneous pallidal DBS, with a minimum follow-up period lasting 24 months (range 24–30 months). The mean dose of levodopa in these patients could not be changed significantly after the procedure and pergolide was added after 12 months in five patients because of recurring fluctuations despite adjustments in stimulation parameters. All but two patients had no fluctuations until 9 months. Two of the patients reported barely perceptible fluctuations at 12 months and two at 15 months; however, two patients remain without fluctuations at 2 years. The mean improvements in the UPDRS motor score in the off time and the activities of daily living (ADL) score were more than 50%; the mean off time decreased from 40 to 10%, and the mean dyskinesia and complication of treatment scores were reduced to one-third until pergolide was introduced at 12 months. No significant improvement in “on” scores was observed. A slight worsening after 1 year was observed and three patients developed levodopa- and stimulation-resistant gait ignition failure and minimal fluctuations at 1 year. Side effects, which were controlled by modulation of stimulation, included dysarthria, dystonia, and confusion. Conclusions. Bilateral pallidal DBS is safe and efficient in patients who have levodopa-responsive parkinsonism with severe fluctuations. Major improvements in motor score, ADL score, and off time persisted beyond 2 years after the operation, but signs of decreased efficacy started to be seen after 12 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus
Benabid, A. L., Pollak, P., Hoffmann, D., Gervason, C., Hommel, M., Perret, J. E., de Rougemont, J., & Gao, D. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91175-t · Cited by 1,787
Cited by
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa000827 · Cited by 1,514
Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
Follett, K. A., Weaver, F. M., Stern, M., Hur, K., Harris, C. L., Luo, P., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907083 · Cited by 1,355
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up
Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J.-L., Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M. I., et al. (2005) · Brain · doi:10.1093/brain/awh571 · Cited by 1,057
Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027
“Today, DBS is widely used as a treatment for symptoms of Parkinson's disease (Ghika et al, 1998; Greenberg and Rezai, 2003; McClelland et al, 2005).”
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
An algorithm (decision tree) for the management of Parkinson’s disease (2001): Treatment Guidelines
Olanow, C. W., Watts, R. L., & Koller, W. C. (2001) · Neurology · doi:10.1212/wnl.56.suppl_5.s1 · Cited by 715
Saint-Cyr, J. A. (2000) · Brain · doi:10.1093/brain/123.10.2091 · Cited by 554
Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease
Anderson, V. C., Burchiel, K. J., Hogarth, P., Favre, J., & Hammerstad, J. P. (2005) · Archives of Neurology · doi:10.1001/archneur.62.4.554 · Cited by 537
Self-citationMoro, E., Lozano, A. M., Pollak, P., Agid, Y., Rehncrona, S., Volkmann, J., Kulisevsky, J., Obeso, J. A., Albanese, A., Hariz, M. I., et al. (2010) · Movement Disorders · doi:10.1002/mds.22735 · Cited by 468
Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
Weaver, F. M., Follett, K. A., Stern, M., Luo, P., Harris, C. L., Hur, K., Marks, W. J., Rothlind, J., Sagher, O., Moy, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31825dcdc1 · Cited by 452
Temel, Y., Kessels, A., Tan, S., Topdag, A., Boon, P., & Visser-Vandewalle, V. (2006) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.01.004 · Cited by 424
How do parkinsonian signs return after discontinuation of subthalamic DBS?
Temperli, P., Ghika, J., Villemure, J.-G., Burkhard, P. R., Bogousslavsky, J., & Vingerhoets, F. J. G. (2003) · Neurology · doi:10.1212/wnl.60.1.78 · Cited by 418
Self-citationBurchiel, K. J., Anderson, V. C., Favre, J., & Hammerstad, J. P. (1999) · Neurosurgery · doi:10.1097/00006123-199912000-00024 · Cited by 371
Self-citationGross, R. E., Krack, P., Rodriguez-Oroz, M. C., Rezai, A. R., & Benabid, A.-L. (2006) · Movement Disorders · doi:10.1002/mds.20960 · Cited by 324
Treatments for dysarthria in Parkinson's disease
Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-Dowsey, P., & Auzou, P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00854-3 · Cited by 315
Subthalamic DBS replaces levodopa in Parkinson’s disease: Two-year follow-up
Vingerhoets, F. J. G., Villemure, J.-G., Temperli, P., Pollo, C., Pralong, E., & Ghika, J. (2002) · Neurology · doi:10.1212/wnl.58.3.396 · Cited by 314
Self-citationDeep brain stimulation: Postoperative issues
Deuschl, G., Herzog, J., Kleiner-Fisman, G., Kubu, C., Lozano, A. M., Lyons, K. E., Rodriguez-Oroz, M. C., Tamma, F., Tröster, A. I., Vitek, J. L., et al. (2006) · Movement Disorders · doi:10.1002/mds.20957 · Cited by 313
Deep brain stimulation: Preoperative issues
Lang, A. E., Houeto, J.-L., Krack, P., Kubu, C., Lyons, K. E., Moro, E., Ondo, W., Pahwa, R., Poewe, W., Tröster, A. I., et al. (2006) · Movement Disorders · doi:10.1002/mds.20955 · Cited by 308
Deep Brain Stimulation for the Treatment of Parkinson’s Disease
Volkmann, J. (2004) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200401000-00003 · Cited by 298
Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients
Umemura, A., Jaggi, J. L., Hurtig, H. I., Siderowf, A. D., Colcher, A., Stern, M. B., & Baltuch, G. H. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.4.0779 · Cited by 279
Long‐term results of bilateral pallidal stimulation in Parkinson's disease
Volkmann, J., Allert, N., Voges, J., Sturm, V., Schnitzler, A., & Freund, H. (2004) · Annals of Neurology · doi:10.1002/ana.20091 · Cited by 261
Suicide after successful deep brain stimulation for movement disorders
Burkhard, P. R., Vingerhoets, F. J. G., Berney, A., Bogousslavsky, J., Villemure, J.-G., & Ghika, J. (2004) · Neurology · doi:10.1212/01.wnl.0000145603.48221.b5 · Cited by 219
Self-citationCurrent applications and limitations of surgical treatments for movement disorders
Krack, P., Martinez‐Fernandez, R., del Alamo, M., & Obeso, J. A. (2017) · Movement Disorders · doi:10.1002/mds.26890 · Cited by 122
“A more limited number of early publications on GPiDBS in PD, which also provide evidence of positive outcomes, are available.(29,31,35,36) UPDRS III score improvements varied from 39% to 56%.”
BackgroundInfluential
Metadata
- Authors
- Ghika, J., Villemure, J.-G., Fankhauser, H., Favre, J., Assal, G., & Ghika-Schmid, F.
- Venue
- Journal of Neurosurgery
- Published
- 1998-11
- Volume
- 89
- Issue
- 5
- Pages
- 713-718
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2143395271
- Cited by
- 250
- References
- 1
- FWCI
- 10.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.